24/08/2026
🎉 A proud milestone for NAAMII and Nepal’s AI community! 🇳🇵
We are thrilled to share that a medical AI platform for lower-limb medical image analysis and surgical planning, with its core AI research and development led by our MAP-MED Lab at NAAMII for U.S.-based medical technology company Planning Logic AI, has officially received U.S. FDA 510(k) clearance.
For us, this is more than a regulatory milestone. It demonstrates that high-quality, clinically validated medical AI can be researched and developed in Nepal to meet the technical, clinical, quality, and regulatory requirements of the U.S. healthcare market.
Our team contributed across AI algorithm development, validation, clinical evaluation, and rigorous regulatory documentation, reflecting the dedication and technical strength of our multidisciplinary researchers and engineers.
We are deeply grateful to the clinicians, regulatory experts, consultants, executive leadership, collaborators, and industry partners who supported this journey.
🚀 We are also expanding our team to continue the R&D on this project. Researchers and engineers with 3–5 years of experience in medical imaging, medical AI, or related fields, as well as PhD graduates and researchers with relevant expertise, are encouraged to contact us at [email protected].
This is a proud moment for NAAMII, our MAP-MED Lab, and Nepal’s growing AI ecosystem. We look forward to continuing to build world-class medical AI from Nepal for global impact.